aTyr Pharma ATYR Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's short-term investments?
- aTyr Pharma (ATYR) reported short-term investments of $56.51M in Q1 2026.
- How has aTyr Pharma's short-term investments changed year-over-year?
- aTyr Pharma's short-term investments decreased by 14.4% year-over-year, from $65.99M to $56.51M.
- What is the long-term trend for aTyr Pharma's short-term investments?
- Over 5 years (2020 to 2025), aTyr Pharma's short-term investments has grown at a 35.8% compound annual growth rate (CAGR), from $14.74M to $67.94M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.